Jan Schlomach

Title: Innovator Jan Schlomach: Pioneering Medical Advancements in Basel

Introduction: Jan Schlomach is an esteemed inventor based in Basel, Switzerland, renowned for his significant contributions to the field of medicine. With one patented innovation, Schlomach has made strides in developing treatments that target various medical conditions through novel chemical compounds.

Latest Patents: Schlomach's notable patent is for the invention titled "Sacubitril Calcium Salts." This invention pertains to polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. The patented calcium salt exhibits potential in treating various conditions and disorders that are responsive to the inhibition of neutral endopeptidases.

Career Highlights: Jan Schlomach is affiliated with Novartis AG, a global healthcare company recognized for its commitment to innovation and research in pharmaceuticals. His work focuses on enhancing the therapeutic potential of novel compounds, and through his innovative research, he has contributed to the advancement of medical therapies.

Collaborations: Throughout his career, Schlomach has collaborated with fellow researchers and professionals, including David Hook and Bin Hu. These collaborations have allowed him to further develop his ideas and refine his inventions, fostering an environment of creativity and knowledge-sharing.

Conclusion: Jan Schlomach exemplifies the spirit of innovation within the pharmaceutical industry. His patented work on Sacubitril calcium salts demonstrates his dedication to finding new treatments that can significantly impact patients' lives. As he continues his work with Novartis AG, Schlomach remains a vital contributor to the ongoing quest for medical advancements.